About Arrow® from Teleflex

We are a global leader focused on reducing vascular-related complications through world-class solutions designed to equally benefit clinicians and patients. Our goal is to provide intuitive products and consultative programs that improve procedural efficiencies, patient outcomes, and healthcare economic value to advance care in Vascular Access.

Customer Support - Latin America









Federal Law (USA) restricts these devices to sale by or on the order of a physician.

Contraindication: The Arrowg+ard Blue Plus CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.

Contraindication: Clinical assessment of the patient must be completed to ensure no contraindications exist. The Arrowg+ard Blue Advance PICC is contraindicated in the following areas:
• Patients with known hypersensitivity to chlorhexidine
• In presence of device related infections
• In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, and Arrowg+ard Blue Plus are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. Please check your local regulatory approval status. Refer to the applicable Instructions for Use for the indications approved in your geography. Information in this material is not a substitute for the product Instructions for Use. This document does not imply compatibility between devices. Not all products may be available in all countries. Please contact your local representative. Revised: 08/2022. ©2022 Teleflex Incorporated. All rights reserved. MC-007978 LA EN